| Biotech Networks Partner Content | ![]() |
Register by November 11 for maximum savings - Final agenda now available
30th Molecular & Precision Med TRI-CON | March 6-8, 2023 | Hilton San Diego Bayfront | San Diego, California
REGISTER |VIEW PROGRAMS | DOWNLOAD FINAL AGENDA
Implementing Precision Medicine |
Precision Health |
||
| Digital Medicine | Diagnostics Innovation and Market Access | ||
| At-Home & Point-of-Care Diagnostics | Infectious Disease Diagnostics | ||
| Liquid Biopsy | Multi-Cancer Early Detection | ||
| Spatial Biology | Single-Cell Multiomics |
FEATURED KEYNOTE PRESENTATION
Celebrating 30 Years of Genomics Innovation FIRESIDE CHAT: |
FEATURED SPEAKERS
| Euan Ashley Professor, Genomics & Precision Health Stanford |
Molly He CEO Element Bioscience |
||
| Mark Fidock VP, Diagnostic Development AstraZeneca |
Sarah Hersey VP, Precision Medicine Bristol Myers Squibb |
||
| Bruce J. Tromberg Director National Institute of Biomedical Imaging and Bioengineering, NIH |
Mara Aspinall Managing Director BlueStone Venture Partners |
||
| Stephen F. Kingsmore President & CEO Rady Children's Hospital |
Esther Babady Section Head, Clinical Microbiology Memorial Sloan Kettering Cancer Center |
||
| Eric Dishman Former Director, All of Us Research Program NIH |
Alicyn Campbell Head, Digital Health Oncology AstraZeneca |
||
| Christopher M. Hartshorn Chief, Digital & Mobile Technologies NCATS, NIH |
Razelle Kurzrock Chair, Clinical Trials Committee WIN for Personalized Cancer Therapy |
||
| Howard I. Scher Head, Biomarker Development Memorial Sloan Kettering Cancer Center |
Jacqueline Shreibati Senior Clinical Lead, Consumer Health |
||
| Tom Miller Managing Partner GreyBird Ventures |
Lourdes Barrera Executive Director, Precision Medicine Merck |
||
| Philip E. Castle Director, Cancer Prevention NCI, NIH |
Hoi-Ying Elsie Yu Director, Point-of-Care Testing Geisinger Health System |
||
| Nathan Ledeboer Vice Chair, Pathology Medical College of Wisconsin |
Michael Snyder Director, Genomics & Personalized Medicine Stanford University |
||
| Edward Abrahams President Personalized Medicine Coalition |
Marielena Mata Diagnostic Lead, Oncology Pfizer |
||
| Christopher Conn Global Director, Diagnostics Strategy Amgen |
Larry Kessler Deputy Chair MCED Consortium |
||
| Kenna R. Mills-Shaw Executive Director, Personalized Cancer Therapy MD Anderson Cancer Center |
KEY CONTACTS
| For more details on the conference, please contact: Julia Boguslavsky, Executive Director, Conferences, Cambridge Healthtech Institute Email: juliab@healthtech.com |
|
| For additional information regarding sponsorship and exhibit availability, please contact: Jon Stroup, Sr. Manager, Business Development 781-972-5483 - jstroup@healthtech.com |
SPONSORSHIP & EXHIBITOR OPPORTUNITIES
PREMIER SPONSORS
CORPORATE SPONSORS
|
|||
|
|
|
|
CORPORATE SUPPORT SPONSORS
|
|
|
|
|
|||
CHI, 250 First Avenue, Suite 300,
Needham, MA 02494 -Tel: 781-972-5400 | Fax: 781-972-5425.